Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system. | Genes Dis | 2023 | 37396554 | PubTator, text mining | PubMed |
| GATA zinc finger protein p66β promotes breast cancer cell migration by acting as a co-activator of Snail. | Cell Death Dis | 2023 | 37380643 | PubTator, text mining | PubMed |
| Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers. | Int J Mol Sci | 2023 | 37373333 | PubTator, text mining | PubMed |
| Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine-Panobinostat Combination. | Cancers (Basel) | 2023 | 37370721 | PubTator, text mining | PubMed |
| Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment. | Cancers (Basel) | 2023 | 37345170 | PubTator, text mining | PubMed |
| Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 37345159 | PubTator, text mining | PubMed |
| WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells. | Cancers (Basel) | 2023 | 37345102 | PubTator, text mining | PubMed |
| The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology. | Cancers (Basel) | 2023 | 37345019 | PubTator, text mining | PubMed |
| Steering CAR T cell epigenetic programs by tweaking manufacturing protocol. | Cell Rep Med | 2023 | 37343521 | PubTator, text mining | PubMed |
| BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer. | Sci Transl Med | 2023 | 37343085 | PubTator, text mining | PubMed |
| Intrinsic catalytic properties of histone H3 lysine-9 methyltransferases preserve monomethylation levels under low S-adenosylmethionine. | J Biol Chem | 2023 | 37331600 | PubTator, text mining | PubMed |
| The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity. | J Exp Clin Cancer Res | 2023 | 37308974 | PubTator, text mining | PubMed |
| BRD4770 inhibits vascular smooth muscle cell proliferation via SUV39H2, but not EHMT2 to protect against neointima formation. | Hum Cell | 2023 | 37306883 | PubTator, text mining | PubMed |
| DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer. | Clin Epigenetics | 2023 | 37301955 | PubTator, text mining | PubMed |
| Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy. | Cancers (Basel) | 2023 | 37296931 | PubTator, text mining | PubMed |
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine. | EPMA J | 2023 | 37275549 | PubTator, text mining | PubMed |
| A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation. | Retrovirology | 2023 | 37268923 | PubTator, text mining | PubMed |
| Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity. | Cancer Cell | 2023 | 37267951 | PubTator, text mining | PubMed |
| Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas. | Nat Commun | 2023 | 37253849 | PubTator, text mining | PubMed |
| Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci. | Cancer Res | 2023 | 37249603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=14